{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T21:15:02Z","timestamp":1776806102417,"version":"3.51.2"},"reference-count":45,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.3892\/ol.2012.651","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T18:06:48Z","timestamp":1332526008000},"page":"1181-1185","source":"Crossref","is-referenced-by-count":18,"title":["Proposed medications for taxane-induced myalgia and arthralgia (Review)"],"prefix":"10.3892","volume":"3","author":[{"given":"ATSUSHI","family":"IMAI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KAZUTOSHI","family":"MATSUNAMI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIROSHI","family":"TAKAGI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SATOSHI","family":"ICHIGO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2012,3,23]]},"reference":[{"issue":"Suppl 3","key":"key20180108091653_b1-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/sj.bjc.6601496","article-title":"The taxanes: toxicity and quality of life considerations in advanced ovarian cancer","volume":"89","author":"Guastalla","year":"2003","journal-title":"Br J Cancer"},{"key":"key20180108091653_b2-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/BF02968008","article-title":"Mechanism of taxane neurotoxicity","volume":"11","author":"Hagiwara","year":"2004","journal-title":"Breast Cancer"},{"key":"key20180108091653_b3-ol-03-06-1181","first-page":"35","article-title":"Melatonin, a promising role in taxane-related neuropathy","volume":"28","author":"Nahleh","year":"2010","journal-title":"Clin Med Insights Oncol"},{"key":"key20180108091653_b4-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1517\/14656566.7.8.1041","article-title":"Albumin-bound paclitaxel: a next-generation taxane","volume":"7","author":"Gradishar","year":"2006","journal-title":"Expert Opin Pharmacother"},{"key":"key20180108091653_b5-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejca.2005.06.030","article-title":"Peripheral neuropathy: a persisting challenge in paclitaxel-based regimes","volume":"42","author":"Mielke","year":"2006","journal-title":"Eur J Cancer"},{"key":"key20180108091653_b6-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/oxfordjournals.annonc.a059220","article-title":"Paclitaxel-induced neuropathy","volume":"6","author":"Postma","year":"1995","journal-title":"Ann Oncol"},{"key":"key20180108091653_b7-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1212\/WNL.47.1.115","article-title":"Motor neuropathy due to docetaxel and paclitaxel","volume":"47","author":"Freilich","year":"1996","journal-title":"Neurology"},{"key":"key20180108091653_b8-ol-03-06-1181","first-page":"2337","article-title":"Amifostine protects against chemotherapy-induced neurotoxicity: an in vitro investigation","volume":"24","author":"Verstappen","year":"2004","journal-title":"Anticancer Res"},{"key":"key20180108091653_b9-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF02968011","article-title":"Treatment and care of neurotoxicity from taxane anticancer agents","volume":"11","author":"Makino","year":"2004","journal-title":"Breast Cancer"},{"key":"key20180108091653_b10-ol-03-06-1181","first-page":"5756","article-title":"Paclitaxel and cisplatin-induced neurotoxicity: a protective role of acetyl-l-carnitine","volume":"15","author":"Pisano","year":"2003","journal-title":"Clin Cancer Res"},{"key":"key20180108091653_b11-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2354.2008.00996.x","article-title":"Long-term glutamate supplementation failed to protect against peripheral neurotoxicity of paclitaxel","volume":"18","author":"Loven","year":"2009","journal-title":"Eur J Cancer Care (Engl)"},{"key":"key20180108091653_b12-ol-03-06-1181","first-page":"233","article-title":"Prevention of paclitaxel-associated arthralgias and myalgias","volume":"1","author":"Markman","year":"2003","journal-title":"J Support Oncol"},{"key":"key20180108091653_b13-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.devbrainres.2004.10.017","article-title":"Superoxide dismutase isoforms 1 and 2 in lumbar spinal cord of neonatal rats after sciatic nerve transection and melatonin treatment","volume":"154","author":"Rog\u00e9rio","year":"2005","journal-title":"Brain Res Dev Brain Res"},{"key":"key20180108091653_b14-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1034\/j.1600-079x.2002.1816.x","article-title":"Melatonin attenuates the neuronal NADPH-d\/NOS expression in the nodose ganglion of acute hypoxic rats","volume":"32","author":"Chang","year":"2002","journal-title":"J Pineal Res"},{"key":"key20180108091653_b15-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-079X.1997.tb00329.x","article-title":"A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical state","volume":"23","author":"Lissoni","year":"1997","journal-title":"J Pineal Res"},{"key":"key20180108091653_b16-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/BF01262569","article-title":"Treatment of cancer chemotherapy-induced toxicity with the pineal hormone melatonin","volume":"5","author":"Lissoni","year":"1997","journal-title":"Support Care Cancer"},{"issue":"Suppl 11","key":"key20180108091653_b17-ol-03-06-1181","first-page":"8","article-title":"Protection of normal tissues from the cytotoxic effects of chemotherapy by amifostine (ethyol): clinical experiences","volume":"21","author":"Capizzi","year":"1994","journal-title":"Semin Oncol"},{"key":"key20180108091653_b18-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1006\/gyno.1999.5545","article-title":"The effect of amifostine on the in vitro cytotoxicity of chemotherapeutic agents in three epithelial ovarian carcinoma cell lines","volume":"75","author":"Ng","year":"1999","journal-title":"Gynecol Oncol"},{"issue":"2 Suppl 7","key":"key20180108091653_b19-ol-03-06-1181","first-page":"82","article-title":"Neurologic protection by amifostine","volume":"26","author":"DiPaola","year":"1999","journal-title":"Semin Oncol"},{"key":"key20180108091653_b20-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1200\/JCO.1999.17.10.3038","article-title":"Randomized phase II study of high-dose paclitaxel with or without amifostine in patients with metastatic breast cancer","volume":"17","author":"Gelmon","year":"1999","journal-title":"J Clin Oncol"},{"key":"key20180108091653_b21-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00000421-200108000-00020","article-title":"Pharmacologic study of paclitaxel administered with or without the cytoprotective agent amifostine, and given as a single agent or in combination with epirubicin and cisplatin in patients with advanced solid tumors","volume":"24","author":"Van den Brande","year":"2001","journal-title":"Am J Clin Oncol"},{"key":"key20180108091653_b22-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/annonc\/mdg301","article-title":"Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients","volume":"14","author":"Lorusso","year":"2003","journal-title":"Ann Oncol"},{"key":"key20180108091653_b23-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00520-005-0782-y","article-title":"Neuroprotection with amifostine in the first-line treatment of advanced ovarian cancer with carboplatin\/paclitaxel-based chemotherapy \u2013 a double-blind, placebo-controlled, randomized phase II study from the Arbeitsgemeinschaft Gyn\u00e4kologische Onkologie (AGO) ovarian cancer study group","volume":"13","author":"Hilpert","year":"2005","journal-title":"Support Care Cancer"},{"key":"key20180108091653_b24-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1200\/JCO.1999.17.1.434a","article-title":"Use of gabapentin to treat taxane-induced myalgias","volume":"17","author":"Van Deventer","year":"1999","journal-title":"J Clin Oncol"},{"key":"key20180108091653_b25-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1200\/JCO.2004.99.298","article-title":"Use of gabapentin in the prevention of taxane-induced arthralgias and myalgias","volume":"22","author":"Nguyen","year":"2004","journal-title":"J Clin Oncol"},{"key":"key20180108091653_b26-ol-03-06-1181","first-page":"2927","article-title":"Role of pregabalin in treatment of oxaliplatin-induced sensory neuropathy","volume":"30","author":"Saif","year":"2010","journal-title":"Anticancer Res"},{"key":"key20180108091653_b27-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clinthera.2007.01.013","article-title":"Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders","volume":"29","author":"Tassone","year":"2007","journal-title":"Clin Ther"},{"key":"key20180108091653_b28-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00003495-200565010-00011","article-title":"Pregabalin: in the treatment of postherpetic neuralgia","volume":"65","author":"Frampton","year":"2005","journal-title":"Drugs"},{"key":"key20180108091653_b29-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.2165\/00003495-200464240-00006","article-title":"Pregabalin: in the treatment of painful diabetic peripheral neuropathy","volume":"64","author":"Frampton","year":"2004","journal-title":"Drugs"},{"key":"key20180108091653_b30-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1345\/aph.1G078","article-title":"Pregabalin: a new neuromodulator with broad therapeutic indications","volume":"39","author":"Shneker","year":"2005","journal-title":"Ann Pharmacother"},{"key":"key20180108091653_b31-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00280-007-0584-7","article-title":"Successful amelioration of oxaliplatin-induced hyperexcitability syndrome with the antiepileptic pregabalin in a patient with pancreatic cancer","volume":"61","author":"Saif","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20180108091653_b32-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jpainsymman.2006.07.006","article-title":"Efficacy of pregabalin in the management of cetuximab-related itch","volume":"32","author":"Porzio","year":"2006","journal-title":"J Pain Symptom Manage"},{"key":"key20180108091653_b33-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/annonc\/mdn698","article-title":"Relationship between GSTP Ile(105)Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicity","volume":"20","author":"Mir","year":"2009","journal-title":"Ann Oncol"},{"key":"key20180108091653_b34-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1200\/JCO.2002.07.061","article-title":"Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial","volume":"20","author":"Cascinu","year":"2002","journal-title":"J Clin Oncol"},{"key":"key20180108091653_b35-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejpain.2008.03.003","article-title":"Herbal medicine shakuyaku-kanzo-to reduces paclitaxel-induced painful peripheral neuropathy in mice","volume":"13","author":"Hidaka","year":"2009","journal-title":"Eur J Pain"},{"key":"key20180108091653_b36-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1006\/gyno.2001.6168","article-title":"Effects of shakuyaku-kanzo-to on muscle pain from combination chemotherapy with paclitaxel and carboplatin","volume":"81","author":"Yamamoto","year":"2001","journal-title":"Gynecol Oncol"},{"key":"key20180108091653_b37-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00520-008-0508-z","article-title":"The efficacy of prophylactic Shakuyaku-Kanzo-to for myalgia and arthralgia following carboplatin and paclitaxel combination chemotherapy for non-small cell lung cancer","volume":"17","author":"Yoshida","year":"2009","journal-title":"Support Care Cancer"},{"key":"key20180108091653_b38-ol-03-06-1181","first-page":"537","article-title":"The efficacy of Shakuyaku-Kanzo-to for peripheral nerve dysfunction in paclitaxel combination chemotherapy for epithelial ovarian carcinoma","volume":"31","author":"Fujii","year":"2004","journal-title":"Gan To Kagaku Ryoho"},{"key":"key20180108091653_b39-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1006\/gyno.1998.5226","article-title":"Use of low-dose oral prednisone to prevent paclitaxel-induced arthralgias and myalgias","volume":"72","author":"Markman","year":"1999","journal-title":"Gynecol Oncol"},{"key":"key20180108091653_b40-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1200\/JCO.1998.16.12.3918","article-title":"Glutamine treatment of paclitaxel-induced myalgias and arthralgias","volume":"16","author":"Savarese","year":"1998","journal-title":"J Clin Oncol"},{"key":"key20180108091653_b41-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0305-7372(03)00133-6","article-title":"Prevention of chemotherapy and radiation toxicity with glutamine","volume":"29","author":"Savarese","year":"2003","journal-title":"Cancer Treat Rev"},{"key":"key20180108091653_b42-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1634\/theoncologist.2007-0217","article-title":"Prevention of docetaxel- or paclitaxel-associated taste alterations in cancer patients with oral glutamine: a randomized, placebo-controlled, double-blind study","volume":"13","author":"Strasser","year":"2008","journal-title":"Oncologist"},{"key":"key20180108091653_b43-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0304-3959(01)00294-9","article-title":"Vincristine-induced allodynia in the rat","volume":"93","author":"Nozaki-Taguchi","year":"2001","journal-title":"Pain"},{"key":"key20180108091653_b44-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1200\/JCO.1996.14.1.233","article-title":"Cyclosporin A does not reverse clinical resistance to paclitaxel in patients with relapsed non-Hodgkin's lymphoma","volume":"14","author":"Sarris","year":"1996","journal-title":"J Clin Oncol"},{"key":"key20180108091653_b45-ol-03-06-1181","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/jnci\/85.8.676","article-title":"Antihistamines in the treatment of taxol-induced paroxystic pain syndrome","volume":"85","author":"Martoni","year":"1993","journal-title":"J Natl Cancer Inst"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2012.651\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T09:45:39Z","timestamp":1515404739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2012.651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,23]]},"references-count":45,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,3,23]]},"published-print":{"date-parts":[[2012,6]]}},"alternative-id":["10.3892\/ol.2012.651"],"URL":"https:\/\/doi.org\/10.3892\/ol.2012.651","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,23]]}}}